Compare STLD & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STLD | PODD |
|---|---|---|
| Founded | 1993 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5B | 22.1B |
| IPO Year | 1996 | 2007 |
| Metric | STLD | PODD |
|---|---|---|
| Price | $165.31 | $304.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 19 |
| Target Price | $174.00 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 1.2M | 765.6K |
| Earning Date | 01-21-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.51 | 3.45 |
| Revenue | ★ $17,634,671,000.00 | $2,521,800,000.00 |
| Revenue This Year | $7.16 | $32.55 |
| Revenue Next Year | $9.40 | $20.39 |
| P/E Ratio | ★ $22.01 | $88.24 |
| Revenue Growth | N/A | ★ 27.11 |
| 52 Week Low | $103.17 | $230.05 |
| 52 Week High | $172.94 | $354.88 |
| Indicator | STLD | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 59.67 | 40.94 |
| Support Level | $152.54 | $303.20 |
| Resistance Level | $172.94 | $317.34 |
| Average True Range (ATR) | 4.33 | 13.12 |
| MACD | 0.48 | -2.82 |
| Stochastic Oscillator | 62.60 | 3.14 |
Steel Dynamics Inc operates as a domestic steel producer and metal recycler in the United States. The company's product portfolio comprises hot rolled sheet, hot rolled plate, painted sheet products, cold rolled sheet, and others. Its reportable segments are steel operations, metals recycling operations, steel fabrication operations, and aluminum operations. Maximum revenue is generated from its steel operations segment, which consists of manufacturing various steel products and numerous coating operations. Its primary sources of revenue are currently from the manufacture and sale of steel products, the processing and sale of recycled ferrous and nonferrous metals, and the fabrication and sale of steel joists and deck products.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.